Spots Global Cancer Trial Database for esophagus
Every month we try and update this database with for esophagus cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer | NCT00160875 | Esophageal Canc... | Irinotecan hydr... Cisplatin | 18 Years - | University Health Network, Toronto | |
| The French EsoGastricTumours Data Base | NCT02526095 | Esophageal Dise... | 18 Years - 90 Years | University Hospital, Lille | ||
| The French EsoGastricTumours Data Base | NCT02526095 | Esophageal Dise... | 18 Years - 90 Years | University Hospital, Lille | ||
| A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma | NCT03430843 | Esophageal Squa... | Tislelizumab Paclitaxel Docetaxel Irinotecan | 18 Years - | BeiGene | |
| Tissue Oxygenation Are Associated With Anastomotic Leak Rates After an Ivor Lewis Esophagectomy | NCT01551433 | Esophageal Canc... | wireless pulse ... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer | NCT00215644 | Esophageal Canc... Gastric Cancer | Matuzumab Epirubicin Cisplatin Capecitabine | 18 Years - | Merck KGaA, Darmstadt, Germany | |
| Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia | NCT02464930 | Barrett's Esoph... Gastroesophagea... Esophageal Aden... | 18 Years - | Midwest Veterans' Biomedical Research Foundation | ||
| A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer | NCT00735826 | Aerodigestive T... Lung Cancer Esophageal Canc... Head and Neck C... | Vorinostat | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Open Versus Laparoscopically-assisted Esophagectomy for Cancer | NCT00937456 | Esophageal Canc... | Laparoscopicall... | 18 Years - 75 Years | University Hospital, Lille | |
| Nutritional Support During Induction Therapy for Esophageal Cancer | NCT05314946 | Esophageal Canc... Nutrition Aspec... | No feeding tube... Placement of a ... | 18 Years - | Lawson Health Research Institute | |
| Optical Coherence Tomography (OCT) Based Screening of Esophagus and Gastroesophageal Junction | NCT01401699 | Barrett's Esoph... | Optical Frequen... | - | Massachusetts General Hospital | |
| Effect of Zinc on Barrett's Metaplasia | NCT01984580 | Barrett's Metap... | zinc gluconate | 18 Years - 80 Years | Main Line Health | |
| Effect of Zinc on Barrett's Metaplasia | NCT01984580 | Barrett's Metap... | zinc gluconate | 18 Years - 80 Years | Main Line Health | |
| Prospective Comparison of Large vs. Small Diameter Esophageal Stents for Palliation of Malignant Dysphagia | NCT01894763 | Esophageal Canc... | Self-expandable... | 18 Years - | Mayo Clinic | |
| Molecular Fluorescence Endoscopy of (Pre)Malignant Esophageal Lesions | NCT03205501 | Barrett Esophag... Esophageal Canc... Dysplasia in Ba... | IV-administatio... Molecular Fluor... | 18 Years - | University Medical Center Groningen | |
| Circulating Tumor DNA (ctDNA) in Locally Advanced Esophageal and Gastroesophageal (GE) Junction Adenocarcinoma | NCT05067842 | Adenocarcinoma ... | Circulating tum... | 18 Years - 80 Years | Medical College of Wisconsin | |
| A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer | NCT01246960 | Stomach Cancer Esophageal Canc... | Ramucirumab Placebo Oxaliplatin Leucovorin 5-Fluorouracil | 18 Years - | Eli Lilly and Company | |
| Novel Method of Surveillance in Barrett's Esophagus | NCT00955019 | Barrett Esophag... | 18 Years - 90 Years | Mayo Clinic | ||
| Optical Frequency Domain Imaging (OFDI) Assessment in Radiofrequency Ablation | NCT01439594 | Barrett's Esoph... | MGH OFDI Imagin... | 18 Years - | Massachusetts General Hospital | |
| Effect of Antireflux Therapy on the Expression of Genes in Patients With GERD | NCT00624546 | GERD Gastroesophagea... | Prevacid Soluta... Antireflux surg... | 18 Years - 74 Years | University of Rochester | |
| Molecular Fluorescence Endoscopy of (Pre)Malignant Esophageal Lesions | NCT03205501 | Barrett Esophag... Esophageal Canc... Dysplasia in Ba... | IV-administatio... Molecular Fluor... | 18 Years - | University Medical Center Groningen | |
| Three Field Radical Esophagectomy Versus Two Field Esophagectomy - a Prospective Trial | NCT00193817 | Cancer of Esoph... | Two field vs Th... | 18 Years - 70 Years | Tata Memorial Hospital | |
| Wet Heparinized Suction for Abdominal Cancer | NCT05041335 | Cancer of Pancr... Cancer of Stoma... Cancer of Esoph... Cancer of Liver Cancer | wet heparinzed ... Microsieve No heparin flus... No microsieve | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma | NCT03430843 | Esophageal Squa... | Tislelizumab Paclitaxel Docetaxel Irinotecan | 18 Years - | BeiGene | |
| KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer | NCT02205463 | Esophageal Canc... Stomach Cancer | KD019 | 18 Years - | NYU Langone Health | |
| Esophageal Stump Washout | NCT01980394 | Esophageal Canc... Gastrooesophage... | Esophageal Stum... | 18 Years - 95 Years | Kantonsspital Liestal | |
| Decreasing Postoperative Complications by Goal-Directed Fluid Therapy During Esophageal Resection | NCT01416077 | Esophageal Canc... | fluid optimisat... | 18 Years - | University Hospital, Linkoeping | |
| Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer | NCT04018872 | Esophagus Adeno... Esophagus Squam... Gastroesophagea... | Itraconazole | 18 Years - | Dallas VA Medical Center | |
| UICC Classification of Esophageal Cancer | NCT01770275 | Esophageal Canc... | 18 Years - | Universitätsklinikum Hamburg-Eppendorf | ||
| Using Spectrally Encoded Confocal Microscopy (SECM) to Visualise the Esophagus Using an SECM Probe | NCT02210039 | Barrett's Esoph... | SECM Probe | 18 Years - | Massachusetts General Hospital | |
| Effect of Zinc on Barrett's Metaplasia | NCT01984580 | Barrett's Metap... | zinc gluconate | 18 Years - 80 Years | Main Line Health | |
| APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers | NCT03165994 | Esophageal Canc... GastroEsophagea... | APX005M Radiation Thera... Paclitaxel Carboplatin Surgical resect... | 18 Years - | Apexigen America, Inc. | |
| Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer | NCT00321958 | Barrett Esophag... Esophageal Neop... Deglutition Dis... GERD Neoplasm | CSA System (Cry... CryoSpray Ablat... | 18 Years - | University of Maryland, Baltimore | |
| Optical Frequency Domain Imaging (OFDI) Assessment in Radiofrequency Ablation | NCT01439594 | Barrett's Esoph... | MGH OFDI Imagin... | 18 Years - | Massachusetts General Hospital | |
| Tamoxifen in Patients With Oesophageal Cancer | NCT02513849 | Cancer Gastrointestina... | Tamoxifen | 18 Years - 95 Years | University of Nottingham | |
| UICC Classification of Esophageal Cancer | NCT01770275 | Esophageal Canc... | 18 Years - | Universitätsklinikum Hamburg-Eppendorf | ||
| Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome | NCT02513784 | Esophageal Aden... Barrett's Esoph... Reflux Esophagi... | Chlorhexidine g... | 18 Years - | Columbia University | |
| Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and Radiation | NCT01627080 | Esophageal Canc... | Cardiac Biomark... | 18 Years - | M.D. Anderson Cancer Center | |
| KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer | NCT02205463 | Esophageal Canc... Stomach Cancer | KD019 | 18 Years - | NYU Langone Health | |
| UICC Classification of Esophageal Cancer | NCT01770275 | Esophageal Canc... | 18 Years - | Universitätsklinikum Hamburg-Eppendorf | ||
| Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction | NCT00442507 | Esophageal Neop... Esophageal Dise... | Erlotinib Avastin | 18 Years - | Washington University School of Medicine | |
| Tissue Oxygenation Are Associated With Anastomotic Leak Rates After an Ivor Lewis Esophagectomy | NCT01551433 | Esophageal Canc... | wireless pulse ... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| Circulating Tumor DNA (ctDNA) in Locally Advanced Esophageal and Gastroesophageal (GE) Junction Adenocarcinoma | NCT05067842 | Adenocarcinoma ... | Circulating tum... | 18 Years - 80 Years | Medical College of Wisconsin | |
| Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients | NCT00526110 | Gastrointestina... | 5-Fluorouracil Docetaxel Oxaliplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett's Esophagus Compared With Standard Endoscopy | NCT02066233 | Barrett's Esoph... | EG Scan II (tra... Standard Endosc... | 18 Years - | Mayo Clinic | |
| Advanced MRI Sequences for Radiation Therapy Treatment Planning | NCT02340715 | Cancer | 18 Years - 89 Years | Medical College of Wisconsin | ||
| Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett's Esophagus Compared With Standard Endoscopy | NCT02066233 | Barrett's Esoph... | EG Scan II (tra... Standard Endosc... | 18 Years - | Mayo Clinic | |
| Cologne Esophageal Response Prediction Study (CERP-Study) | NCT00953511 | Esophageal Canc... | ERCC1 pathways ... | 18 Years - | University of Cologne | |
| A Trial to Compare Preoperative Chemoradiation and Surgery Versus Surgery Alone in Squamous Cell Carcinoma of Oesophagus | NCT01151839 | Esophageal Neop... | Esophagectomy Neoadjuvant che... | 18 Years - 65 Years | All India Institute of Medical Sciences, New Delhi | |
| Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma | NCT00737438 | Esophageal Canc... Gastric Cancer | epirubicin, cis... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Using Spectrally Encoded Confocal Microscopy (SECM) to Visualise the Esophagus Using an SECM Probe | NCT02210039 | Barrett's Esoph... | SECM Probe | 18 Years - | Massachusetts General Hospital | |
| Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer | NCT04018872 | Esophagus Adeno... Esophagus Squam... Gastroesophagea... | Itraconazole | 18 Years - | Dallas VA Medical Center | |
| Tamoxifen in Patients With Oesophageal Cancer | NCT02513849 | Cancer Gastrointestina... | Tamoxifen | 18 Years - 95 Years | University of Nottingham | |
| A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus | NCT02560623 | Barrett Esophag... | Biopsy Biospecimen Col... Endoscopic Proc... Swallowable Spo... | 18 Years - 90 Years | Mayo Clinic | |
| A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations | NCT05199584 | Solid Tumors Wi... | ENV-101 (talade... | 18 Years - | Endeavor Biomedicines, Inc. | |
| TECR & ECM Placement for Esophageal High Grade Dysplasia | NCT02396745 | Barrett Esophag... Esophagus High Grade Dysp... | Subjects underg... | 18 Years - 80 Years | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | |
| Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome | NCT02513784 | Esophageal Aden... Barrett's Esoph... Reflux Esophagi... | Chlorhexidine g... | 18 Years - | Columbia University | |
| Dose Escalated Proton Beam Therapy or Photon Therapy for Esophageal Cancer | NCT03234842 | Esophageal Canc... | Proton Beam The... Photon Radiatio... Chemotherapy | 18 Years - | University of Florida | |
| Prospective Comparison of Large vs. Small Diameter Esophageal Stents for Palliation of Malignant Dysphagia | NCT01894763 | Esophageal Canc... | Self-expandable... | 18 Years - | Mayo Clinic | |
| Rapamycin With Grapefruit Juice for Advanced Malignancies | NCT00375245 | Tumors Neoplasm Metast... | Rapamycin (siro... Grapefruit Juic... | 18 Years - | University of Chicago | |
| Cologne Esophageal Response Prediction Study (CERP-Study) | NCT00953511 | Esophageal Canc... | ERCC1 pathways ... | 18 Years - | University of Cologne | |
| Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer | NCT04018872 | Esophagus Adeno... Esophagus Squam... Gastroesophagea... | Itraconazole | 18 Years - | Dallas VA Medical Center | |
| Molecular Fluorescence Endoscopy of (Pre)Malignant Esophageal Lesions | NCT03205501 | Barrett Esophag... Esophageal Canc... Dysplasia in Ba... | IV-administatio... Molecular Fluor... | 18 Years - | University Medical Center Groningen | |
| Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer | NCT03578224 | Esophagus | Endoscopic Ultr... Contrast-Enhanc... Fine-Needle Asp... Sonazoid (Perfl... | 21 Years - | Thomas Jefferson University | |
| Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer | NCT00215644 | Esophageal Canc... Gastric Cancer | Matuzumab Epirubicin Cisplatin Capecitabine | 18 Years - | Merck KGaA, Darmstadt, Germany | |
| Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma | NCT00430027 | Esophageal Aden... | Capecitabine Oxaliplatin Cetuximab | 18 Years - | University of Colorado, Denver | |
| Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma | NCT00737438 | Esophageal Canc... Gastric Cancer | epirubicin, cis... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia | NCT02464930 | Barrett's Esoph... Gastroesophagea... Esophageal Aden... | 18 Years - | Midwest Veterans' Biomedical Research Foundation | ||
| Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma | NCT00430027 | Esophageal Aden... | Capecitabine Oxaliplatin Cetuximab | 18 Years - | University of Colorado, Denver |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
